Cargando…

B-cell Complement Dependent Cytotoxic Crossmatch Positivity is an Independent Risk Factor for Long-term Renal Allograft Survival

The clinical significance of positive B-cell complement-dependent cytotoxicity crossmatching (B-CDC) in renal transplant recipients remains unclear. We reviewed 20 recipients with isolated B-CDC positivity at the time of transplantation. We compared the clinical characteristics, acute rejection and...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hwang, Hyeon Seok, Yoon, Hye Eun, Choi, Bum Soon, Oh, Eun Jee, Kim, Ji Il, Moon, In Sung, Kim, Yong Soo, Yang, Chul Woo
Formato:	Texto
Lenguaje:	English
Publicado:	The Korean Academy of Medical Sciences 2011
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3069572/ https://www.ncbi.nlm.nih.gov/pubmed/21468260 http://dx.doi.org/10.3346/jkms.2011.26.4.528

Ejemplares similares

Transplant outcomes in positive complement-dependent cytotoxicity- versus flow cytometry-crossmatch kidney transplant recipients after successful desensitization: a retrospective study
por: Kim, Deok Gie, et al.
Publicado: (2019)

Successful kidney transplantation across a positive complement-dependent cytotoxicity crossmatch by using C1q assay-directed, bortezomib-assisted desensitization: A case report
por: Lee, Juhan, et al.
Publicado: (2017)

Case report: Successful simultaneous heart-kidney transplantation across a positive complement-dependent cytotoxic crossmatch
por: Yamamoto, Takayuki, et al.
Publicado: (2022)

Clinical significance of the presence of anti-human leukocyte antigen-donor specific antibody in kidney transplant recipients with allograft dysfunction
por: Chung, Byung Ha, et al.
Publicado: (2018)

Causes of Positive Pretransplant Crossmatches in the Absence of Donor-Specific Anti-Human Leukocyte Antigen Antibodies: A Single-Center Experience
por: Kang, Hyunhye, et al.
Publicado: (2021)

C1Q Assay Results in Complement-Dependent Cytotoxicity Crossmatch Negative Renal Transplant Candidates with Donor-Specific Antibodies: High Specificity but Low Sensitivity When Predicting Flow Crossmatch
por: Arreola-Guerra, José M., et al.
Publicado: (2016)

Investigation of Serum Angiotensin II Type 1 Receptor Antibodies at the Time of Renal Allograft Rejection
por: Lee, Hyeyoung, et al.
Publicado: (2015)

The Assessment and Outcomes of Crossmatching in Lung Transplantation in Korean Patients
por: Kim, Ha Eun, et al.
Publicado: (2022)

Phasing out the pre-transplant cytotoxicity crossmatch: Are we missing something?
por: Abud, Jamile, et al.
Publicado: (2021)

Clinical Relevance of Pretransplant HLA Class II Donor-specific Antibodies in Renal Transplantation Patients with Negative T-cell Cytotoxicity Crossmatches
por: Song, Eun Young, et al.
Publicado: (2012)

Accuracy of point‐of‐care crossmatching methods and crossmatch incompatibility in critically ill dogs
por: Marshall, Hayden, et al.
Publicado: (2020)

Enhanced virtual crossmatch in intestinal transplantation: association with outcomes and application in practice
por: Moon, Jang Il, et al.
Publicado: (2021)

Successful Renal Transplantation with Desensitization in Highly Sensitized Patients: A Single Center Experience
por: Yoon, Hye Eun, et al.
Publicado: (2009)

Unresolved Subclinical Hypothyroidism is Independently Associated with Progression of Chronic Kidney Disease
por: Kim, Eun Oh, et al.
Publicado: (2013)

A New Trial to Measure ABO Antibodies Using Complement-Dependent Cytotoxicity
por: Youk, Hee-Jeong, et al.
Publicado: (2022)

Implication of a positive virtual crossmatch with negative flow crossmatch: A mind-boggler
por: Chowdhry, Mohit, et al.
Publicado: (2020)

Clinical Significance of HLA-DQ Antibodies in the Development of Chronic Antibody-Mediated Rejection and Allograft Failure in Kidney Transplant Recipients
por: Lee, Hyeyoung, et al.
Publicado: (2016)

Immediate transfusion without crossmatching
por: Moriwaki, Y, et al.
Publicado: (2008)

Impact of high body mass index on allograft outcomes in kidney transplant recipients with presensitization to human leukocyte antigen
por: Park, Yohan, et al.
Publicado: (2021)

Improving Crossmatch Techniques and Graft Outcomes
por: Vincent, L.
Publicado: (2018)

Comparative analysis of Luminex-based donor-specific antibody mean fluorescence intensity values with complement-dependent cytotoxicity & flow crossmatch results in live donor renal transplantation
por: Baranwal, Ajay Kumar, et al.
Publicado: (2017)

Human leukocyte antigen typing and crossmatch: A comprehensive review
por: Althaf, Mohammed Mahdi, et al.
Publicado: (2017)

Comparison of Early and Late Conversion of Sirolimus in Experimental Model of Chronic Cyclosporine Nephropathy
por: Kim, Jin Young, et al.
Publicado: (2012)

Therapeutic Plasma Exchange Ameliorates Incompatible Crossmatches
por: Özen, Mehmet, et al.
Publicado: (2016)

Modified stall‐side crossmatch for transfusions in horses
por: Casenave, Pauline, et al.
Publicado: (2019)

Practical Solutions for Problems in Blood Grouping and Crossmatching
por: Andıç, Neslihan
Publicado: (2022)

Principles of Virtual Crossmatch Testing for Kidney Transplantation
por: Bhaskaran, Madhu C., et al.
Publicado: (2022)

Crossmatch: Alloimmunization versus unspecific agglutination reactions?
por: Giger, Urs
Publicado: (2023)

A positive complement dependent cytotoxicity immunoglobulin G crossmatch due to auto-antibodies with a negative luminex bead assays in a renal transplant recipient: A Diagnostic dilemma
por: Chowdhry, Mohit, et al.
Publicado: (2018)

The Efficacy and Safety of Ezetimibe and Low-Dose Simvastatin as a Primary Treatment for Dyslipidemia in Renal Transplant Recipients
por: Yoon, Hye Eun, et al.
Publicado: (2009)

Progressive Rise in Red Blood Cell Distribution Width Predicts Mortality and Cardiovascular Events in End-Stage Renal Disease Patients
por: Yoon, Hye Eun, et al.
Publicado: (2015)

Clinical Significance of Monitoring Circulating CD4(+)CD25(+) Regulatory T Cells in Kidney Transplantation during the Early Posttransplant Period
por: Kim, Su Hyun, et al.
Publicado: (2009)

Clinical outcomes and effects of treatment in older patients with idiopathic membranous nephropathy
por: Kim, Yaeni, et al.
Publicado: (2019)

The effect of a positive T-lymphocytotoxic crossmatch on clinical outcomes in adult-to-adult living donor liver transplantation
por: Kim, Young-Kyu, et al.
Publicado: (2013)

Virtual and Reality: An Analysis of the UCLA Virtual Crossmatch Exchanges
por: Locke, Arlene F., et al.
Publicado: (2023)

Comparison of Physical Crossmatch and Virtual Crossmatch to Identify Preexisting Donor-Specific Human Leukocyte Antigen (HLA) Antibodies and Outcome Following Kidney Transplantation
por: Peng, Bo, et al.
Publicado: (2019)

Solutions to Avoid False Positives for Rituximab in Pre-Transplant Crossmatches
por: Colmenero Velazquez, Argentina, et al.
Publicado: (2020)

Decisive Indicator for Gastrointestinal Workup in Anemic Patients with Nondialysis Chronic Kidney Disease
por: Hwang, Hyeon Seok, et al.
Publicado: (2012)

Effect of simultaneous presence of anti-blood group A/B and -HLA antibodies on clinical outcomes in kidney transplantation across positive crossmatch: a nationwide cohort study
por: Kwon, Hyunwook, et al.
Publicado: (2019)

NANOG confers resistance to complement-dependent cytotoxicity in immune-edited tumor cells through up-regulating CD59
por: Son, Sung Wook, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_te519k4kkml91sdgcsk7mq5109